Behaviour Toxicology
The new fields of activity material medical and activity embryology investigate the result of specific hepatotoxic exposures in humans and animals on learning, memory, and activity characteristics. 3 vital categories of activity neurotoxicants are metals, solvents, and pesticides. The clearest knowledge on the hurtful effects of antenatal exposure to toxicants comes from the study of 2 metals, lead and mercury, and from epidemiologic investigations of the results of alcohol taken throughout maternity. The less complete knowledge is on the market for 2 alternative teams of agents, solvents and pesticides. What we tend to do to realize their effects on the vertebrate brain is convincing enough to form U.S.A. demand caution in their distribution.
- Insomia.
- sedation.
- Impaired Pyschomotor activity.
Related Conference of Behaviour Toxicology
7th International Conference on Global Toxicology and Risk Assessment
22nd International Conference on Clinical Toxicology and Pharmacology
5th International Conference on Clinical Pharmacology and Toxicology
Behaviour Toxicology Conference Speakers
Recommended Sessions
- Analytical Toxicology
- Applied pharmacology
- Aquatic Toxicology
- Behaviour Toxicology
- Cardiovascular Pharmacology
- Clinical Pharmacological
- Eco-Toxicology
- Experimental and Toxicologic Pathology
- Food Safety and Environmental Toxicology
- Forensic Toxicology
- Genotoxicity
- Immuno Toxicology
- In Vitro Toxicology
- Industrial and Occupational Toxicology
- Medical and Clinical Toxicology
- Medical Development and Safety Testing
- Microbial Toxicology
- Nano toxicology
- Pharmaceutical Toxicology
- Pharmacology
- Pharmacology Testing
- Toxicology
- Toxicology and Risk Assessment
- Toxicology Applications
- Toxicology Testing
Related Journals
Are you interested in
- Analytical Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Aquatic Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Behavior toxicology - clinicalpharmacology2023 (Spain)
- Behavior Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Bio-availability - clinicalpharmacology2023 (Spain)
- Bio-equivalence - clinicalpharmacology2023 (Spain)
- Biochemical Pharmacology - clinicalpharmacology2023 (Spain)
- Biologic drugs - clinicalpharmacology2023 (Spain)
- Chemical Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Clinical and medical pharmacology - clinicalpharmacology2023 (Spain)
- Clinical Pharmacological - GLOBAL TOXICOLOGY 2023 (Portugal)
- Drug discovery and Drug development - clinicalpharmacology2023 (Spain)
- Drug Safety - clinicalpharmacology2023 (Spain)
- Ecological Risk Assessment - GLOBAL TOXICOLOGY 2023 (Portugal)
- Environmental Toxicology - clinicalpharmacology2023 (Spain)
- Experimental and Toxicologic Pathology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Genotoxicity - clinicalpharmacology2023 (Spain)
- Human Health Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Immuno Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- In Vitro Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Medical Development and Safety Testing - GLOBAL TOXICOLOGY 2023 (Portugal)
- Microbial Toxicology - clinicalpharmacology2023 (Spain)
- Microbial Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Molecular Pharmacology - clinicalpharmacology2023 (Spain)
- Nano toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Nanomedicine and Nanotechnology - clinicalpharmacology2023 (Spain)
- Pharmaceutical biotechnology - clinicalpharmacology2023 (Spain)
- Pharmacodynamics - clinicalpharmacology2023 (Spain)
- Pharmacogenomics - clinicalpharmacology2023 (Spain)
- Pharmacokinetics - clinicalpharmacology2023 (Spain)
- Pharmacology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Pharmacology and Toxicology - clinicalpharmacology2023 (Spain)
- Pharmacovigilance - clinicalpharmacology2023 (Spain)
- Route of administration - clinicalpharmacology2023 (Spain)
- Toxic genomic - GLOBAL TOXICOLOGY 2023 (Portugal)
- Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)